LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

Kodu・Aktsiate loetelu・Medpace Holdings Inc

Medpace Holdings Inc

Suletud

SektorTervishoid

305.76 3.64

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

290.56

Max

306.18

Põhinäitajad
By Trading Economics
Sissetulek	-2.4M 115M
Müük	22M 559M
P/E Sektori keskmine	23.931 56.602
Aktsiakasum	3.67
Kasumimarginaal	20.516
Töötajad	5,900
EBITDA	-4.9M 120M

Soovitused
By TipRanks
Soovitused	Neutraalne
12 kuu keskmine prognoos	+9.18% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	21. juuli 2025

Turustatistika
By TradingEconomics
Turukapital	61M 9B
Eelmine avamishind	302.12
Eelmine sulgemishind	305.76

Uudiste sentiment

By Acuity

50%

173 / 382 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Strong Bullish Evidence

300 / 302.88 Toetus ja vastupanu

Medpace Holdings Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

15. mai 2025, 22:52 UTC

Tulu

Suurimad hinnamuutused turgudel

Virgin Galactic Shares Rise on Commercial Spaceflight Plans, Narrower 1Q Loss

15. mai 2025, 20:37 UTC

Peamised uudised

Tulu

Applied Materials Logs Higher 2Q Profit, Revenue as Customer Demand Remains Unchanged

16. mai 2025, 00:00 UTC

Market Talk

Xero Bull Stays Positive on Cost Outlook -- Market Talk

15. mai 2025, 23:47 UTC

Market Talk

Gold Consolidates; Likely Supported by Signs of Disinflation -- Market Talk

15. mai 2025, 23:38 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

15. mai 2025, 23:38 UTC

Market Talk

Nikkei May Edge Higher, Tracking Gains Across Most U.S. Equity Markets -- Market Talk

15. mai 2025, 23:14 UTC

Peamised uudised

Walmart Becomes Biggest Retailer Yet to Pass Through Tariff Price Increases -- 4th Update

15. mai 2025, 22:46 UTC

Peamised uudised

Omandamised, ülevõtmised, äriostud

Bayer Seeks New Roundup Settlement While Exploring Monsanto Bankruptcy -- WSJ

15. mai 2025, 22:46 UTC

Omandamised, ülevõtmised, äriostud

Bayer Working With Restructuring Advisers Latham, AlixPartners to Explore Options for Monsanto -- WSJ

15. mai 2025, 22:46 UTC

Omandamised, ülevõtmised, äriostud

Bayer Exec Says Company Committed to Resolving Roundup Lawsuits in 18 Months -- WSJ

15. mai 2025, 22:46 UTC

Omandamised, ülevõtmised, äriostud

Bayer Seeks New Roundup Settlement While Exploring Monsanto Bankruptcy -- WSJ

15. mai 2025, 21:58 UTC

Tulu

Applied Materials Earnings Beat Expectations. Why the Stock Is Down. -- Barrons.com

15. mai 2025, 21:24 UTC

Tulu

Cava's Earnings Beat Expectations. Growth Was Strong Despite Tariff Fears. -- Barrons.com

15. mai 2025, 20:56 UTC

Market Talk

U.S. Spending Downturn Could Lie Ahead -- Market Talk

15. mai 2025, 20:54 UTC

Market Talk

Tulu

Applied Materials CFO Says Demand Stable Despite Tariffs, Macro -- Market Talk

15. mai 2025, 20:54 UTC

Tulu

Applied Materials Investing to Support Semiconductor Market of More Than $1T by End of Decade, Financial Chief Says

15. mai 2025, 20:51 UTC

Tulu

Applied Materials Financial Chief: Long-Term Secular Growth Drivers Remain Intact

15. mai 2025, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

15. mai 2025, 20:50 UTC

Omandamised, ülevõtmised, äriostud

Berkshire Sells Financial Stocks, Doubles Constellation Stake, Holds Steady on Apple -- WSJ

15. mai 2025, 20:50 UTC

Tulu

Applied Materials' Customer Investments Continue at Expected Rate and Pace, Financial Chief Says

15. mai 2025, 20:47 UTC

Tulu

Applied Materials Not Currently Seeing Large Changes in Customer Demand, CEO Says

15. mai 2025, 20:47 UTC

Tulu

Applied Materials Sees Revenue From Advanced DRAM Customers to Grow 40% in FY25, CEO Says

15. mai 2025, 20:47 UTC

Tulu

Applied Materials Grew Faster Than Peers in Markets Outside China in 2Q, CEO Says

15. mai 2025, 20:47 UTC

Tulu

Applied Materials Underperformed Market in China in 2Q Due to Restrictions on U.S. Companies, CEO Says

15. mai 2025, 20:37 UTC

Tulu

SOS Ltd: Growth Was Fueled by Robust Domestic Demand and Expansion of Pdt Portfolio to Include Rubber and Coal >SOS

15. mai 2025, 20:37 UTC

Tulu

SOS Ltd: Cryptocurrency Mining Rev Declined to $9.3M From $18.9M in FY23, Dip Was Attributed to the Temporary Shutdown of Texas Mining Facility for Upgrades During 1H 2024 >SOS

15. mai 2025, 20:37 UTC

Tulu

SOS Ltd: FY24 Significant Yr-over-Yr Increase in Commodity Trading Rev, Which Soared to $214.3M FY24, 92.6% of Total Rev Up From 74.0% in FY23 >SOS

15. mai 2025, 20:37 UTC

Tulu

SOS Ltd: Cryptocurrency Mining Rev Halves as SOS Focuses on Facility Upgrades and Commodity Expansion >SOS

15. mai 2025, 20:26 UTC

Peamised uudised

Trump Presses Apple to Bring iPhone Manufacturing to America. Wall Street Shrugs. -- WSJ

15. mai 2025, 20:25 UTC

Tulu

Deere Stock Jumps on Guidance Cut. Here's Why. -- Barrons.com

Võrdlus sarnastega

Hinnamuutus

Medpace Holdings Inc Prognoos

Hinnasiht

By TipRanks

9.18% tõus

12 kuu keskmine prognoos

Keskmine 318.5 USD 9.18%

Kõrge 355 USD

Madal 285 USD

Põhineb 7 Wall Streeti analüütiku instrumendi Medpace Holdings Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

7 ratings

Osta

Hoia

Müü

Põhineb 7 analüütiku instrumendi Medpace Holdings Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

300 / 302.88Toetus ja vastupanu

Recent bullish events outweigh bearish events.

All events are bearish.

Sentiment

By Acuity

173 / 382 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Medpace Holdings Inc

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.